PRMT3‐Mediated Arginine Methylation of METTL14 Promotes Malignant Progression and Treatment Resistance in Endometrial Carcinoma

PRMT3‐Mediated Arginine Methylation of METTL14 Promotes Malignant Progression and Treatment Resistance in Endometrial Carcinoma

Abstract Protein arginine methyltransferase (PRMT) plays essential roles in tumor initiation and progression, but its underlying mechanisms in the treatment sensitivity of endometrial cancer (EC) remain unclear and warrant further investigation. Here, a comprehensive analysis of the Cancer Genome At...

Full description

Bibliographic Details
Main Authors: Yiru Wang, Can Wang, Xue Guan, Ying Ma, Shijie Zhang, Fei Li, Yue Yin, Zhenxing Sun, Xiuwei Chen, Hang Yin
Format: Article
Language:English
Published: Wiley 2023-12-01
Series:Advanced Science
Subjects:
endometrial cancer
ferroptosis
METTL14
PRMT3
therapeutic resistance
Online Access:https://doi.org/10.1002/advs.202303812

Internet

https://doi.org/10.1002/advs.202303812

Similar Items